At this time, posts about Korea Union Pharmaceutical are rapidly increasing on portals and securities communities, and today foreigners are tentatively estimated to have net purchased 1,000 shares. Korea Union Pharmaceutical is known as a manufacturer of prescription drugs.


As of 11:30 AM on the 5th, the stock price of Korea Union Pharmaceutical is 16,900 KRW, up 5.96% from the previous day, with a trading volume of 1,736,008 shares, which is about 80.04% of the average trading volume on the 5th. On September 28, Korea Union Pharmaceutical became an issue in the market with the news of a "20% increase in overseas export contracts for Dexamethasone."


In addition to Korea Union Pharmaceutical, posts by investors are also rapidly increasing for Enzychem Lifesciences (183490), Midas AI (222810), and Zenenbio (072520).


Hot Picks Today

"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ① "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①

※Source: AI Investment Assistant AI Racciro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing